arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Aardvark Therapeutics, Inc.

AARD Health Care Biotechnology: Pharmaceutical Preparations
$3.68
▼ -6.6% Today
as of Jun 7, 07:07 ET
Last 30 days -34.17% Apr 28 → Jun 05
$3.44 $4.32 $5.21 $6.09 $6.97 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$3.91
High
$3.98
Low
$3.66
Volume
$130,596
Avg Vol
$187,054
Mkt Cap
$92M
P/E (TTM)
Beta
52w High
$17.94
52w Low
$3.35
Div Yield
Shares Out
$22M

Overview

52-week range
$3.35
$18
2% of range
Avg surprise (last 2)
-11.8%
Avg reaction (last 2)
-9.4%
0% positive
Latest IV / EM
29%
EM ±4.1% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.37$-1.17$-0.96$-0.76$-0.55 Actual $-0.55Actual $-1.37Actual $-1.05Actual $-0.71Est $-0.70Actual $-0.66Actual $-0.75Actual $-0.99Est $-0.81 MarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-22M$-17M$-13M$-9M$-4M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.99 $-0.81 -22.2% -39.4% -4.9% earnings
Tue Sep 30, 2025Sep 2025 $-0.75 financials
Mon Jun 30, 2025Jun 2025 $-0.66 financials
Wed May 14, 2025Mar/2025 $-0.71 $-0.70 -1.4% -13.8% earnings
Mon Sep 30, 2024Sep 2024 $-1.05 financials
Sun Jun 30, 2024Jun 2024 $-1.37 financials
Sun Mar 31, 2024Mar 2024 $-0.55 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$0
Cost of revenue
Gross profit
Operating income$-22M$-18M$-16M$-10M$-5M$-6M
Net income$-22M$-16M$-14M$-9M$-4M$-5M
EPS (diluted)$-0.99$-0.75$-0.66$-0.71$-1.05$-1.37

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$62M$47M$39M$26M$27M$62M
Inventory
Total current assets$94M$112M$129M$145M$155M$74M
Total assets$99M$117M$133M$147M$157M$78M
Long-term debt
Total liabilities$12M$11M$11M$11M$6M$5M
Total equity$87M$107M$122M$137M$151M$-55M$-46M$-42M

Implied volatility — last 90 days

24%26%29%31%34% Jun 07 — IV 29% · EM ±4.1%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.